PT Kalbe Farma Tbk (PTKFF)
0.043
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
PT Kalbe Farma Total Liabilities (Quarterly) : 367.80M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 367.80M |
| December 31, 2025 | 358.07M |
| September 30, 2025 | 318.06M |
| June 30, 2025 | 327.61M |
| March 31, 2025 | 315.12M |
| December 31, 2024 | 300.67M |
| September 30, 2024 | 319.69M |
| June 30, 2024 | 306.91M |
| March 31, 2024 | 305.80M |
| December 31, 2023 | 255.73M |
| September 30, 2023 | 311.10M |
| June 30, 2023 | 376.38M |
| March 31, 2023 | 354.70M |
| December 31, 2022 | 330.43M |
| September 30, 2022 | 330.87M |
| June 30, 2022 | 304.32M |
| March 31, 2022 | 342.25M |
| December 31, 2021 | 308.77M |
| September 30, 2021 | 298.69M |
| June 30, 2021 | 282.11M |
| March 31, 2021 | 308.16M |
| December 31, 2020 | 305.21M |
| September 30, 2020 | 305.64M |
| June 30, 2020 | 343.75M |
| March 31, 2020 | 298.95M |
| Date | Value |
|---|---|
| December 31, 2019 | 256.38M |
| September 30, 2019 | 243.61M |
| June 30, 2019 | 248.89M |
| March 31, 2019 | 233.16M |
| December 31, 2018 | 198.30M |
| September 30, 2018 | 198.16M |
| June 30, 2018 | 273.65M |
| March 31, 2018 | 203.29M |
| December 31, 2017 | 200.64M |
| September 30, 2017 | 219.83M |
| June 30, 2017 | 282.27M |
| March 31, 2017 | 212.91M |
| December 31, 2016 | 205.02M |
| September 30, 2016 | 220.29M |
| June 30, 2016 | 226.65M |
| March 31, 2016 | 219.77M |
| December 31, 2015 | 200.08M |
| September 30, 2015 | 189.13M |
| June 30, 2015 | 203.41M |
| March 31, 2015 | 202.59M |
| December 31, 2014 | 210.54M |
| September 30, 2014 | 229.43M |
| June 30, 2014 | 303.73M |
| March 31, 2014 | 231.49M |
| December 31, 2013 | 231.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 859.67M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
| Veru, Inc. | 8.297M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.882B |
| Shareholders Equity (Quarterly) | 1.430B |
| Debt to Equity Ratio | 0.0126 |
| Current Ratio | 3.556 |
| Net Debt Paydown Yield | 0.13% |